MIRA Pharmaceuticals, Inc. Share Price
MIRAMIRA Pharmaceuticals, Inc. Stock Performance
Open $1.01 | Prev. Close $1.02 | Circuit Range N/A |
Day Range $1.01 - $1.01 | Year Range $0.91 - $2.44 | Volume 485 |
Average Traded $1.01 |
MIRA Pharmaceuticals, Inc. Share Price Chart
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
28-Apr-26 | $1.02 | $1.02 | -1.92% |
24-Apr-26 | $1.04 | $1.04 | +0.00% |
23-Apr-26 | $1.10 | $1.04 | -7.96% |
22-Apr-26 | $1.11 | $1.13 | +4.15% |
21-Apr-26 | $1.08 | $1.08 | -3.13% |
20-Apr-26 | $1.11 | $1.12 | +5.16% |
17-Apr-26 | $1.07 | $1.06 | +1.91% |